Further evidence of the dual role of noradrenaline in regulation of thyrotrophin secretion in male rats

1981 ◽  
Vol 97 (2) ◽  
pp. 213-220 ◽  
Author(s):  
P. T. Männistö ◽  
J. Mattila ◽  
J. Tuomisto

Abstract. The dual role previously suggested for noradrenergic neurons in TRH-TSH regulation was studied in male rats. α-Methyl-p-tyrosine (αMPT) significantly decreased brain noradrenaline (NA) and dopamine (DA) levels 0.5–6 h after the injection. Maximum inhibition of TSH cold-response occurred at 4 h. One h after administration of l-dopa the brain DA (but not NA) level was considerably elevated. TSH cold-response was not significantly changed. The effects of αMPT and Ca-fusarate on the cold-induced TSH secretion were antagonized by neither dihydroxyphenylserine (DOPS; this drug restores NA stores) nor by l-dopa (which restores DA levels). DOPS even potentiated the depressive effect of αMPT and Ca-fusarate. When given into the third ventricle, NA did not modify basal TSH levels but decreased the cold-induced TSH secretion. When infused directly into the median eminence of the medial basal hypothalamus, NA reduced both basal and cold-induced TSH secretion. Pinealectomy decreased the TSH cold-response but NA seemed to retain its ability to inhibit TSH secretion. These results demonstrate that besides the possible stimulatory action on TSH secretion, noradrenergic neurons also have an inhibitory effect outside the blood-brain barrier, possibly in the median eminence.

1983 ◽  
Vol 103 (1) ◽  
pp. 88-94 ◽  
Author(s):  
R. K. Tuominen ◽  
J. Mattila ◽  
P. T. Männistö

Abstract. The effect of histamine (HA) on the coldstimulated and the TRH-induced TSH secretion was studied in male rats utilizing HA and specific HA antagonists and histaminergic drugs as tools. l-histidine (1000 and 1500 mg/kg ip) inhibited the cold-stimulated but not the TRH-induced TSH secretion. Mepyramine (5–50 mg/kg ip) and cimetidine (50–250 mg/kg ip) had no effect on the TSH-cold-response, but the TRH-induced TSH secretion was enhanced by them. HA (1 mg/kg sc), 2-pyridylethylamine (2PEA; 10 mg/kg ip) and impromidine (1 mg/kg sc) decreased the TRH-induced TSH secretion but did not affect the TSH cold-response. When infused into the third ventricle HA (1–50 μg/rat), impromidine (0.1 and 1.0 μg/rat) and 2PEA (50 μg/rat) decreased the cold-stimulated TSH-secretion. The locus of the inhibitory action of HA seems to be both at the anterior pituitary, where it is mediated through H1- and H2-receptors and in the hypothalamus, where the effect appears to be mediated through H2-receptors. At least a part of this particular action might be explained by other mechanisms since neither H1- nor H2-receptor antagonists were able to counteract the effect of HA.


1996 ◽  
Vol 148 (2) ◽  
pp. 291-301 ◽  
Author(s):  
S-K Park ◽  
D A Strouse ◽  
M Selmanoff

Abstract Central catecholaminergic neurones projecting to specific hypothalamic structures are involved in stimulating and inhibiting the activity of the GnRH-containing neurosecretory neurones. Both testosterone and elevated circulating prolactin (PRL) levels inhibit postcastration LH release. Three groups of adult male rats were orchidectomized and adrenalectomized, received corticosterone replacement and were: (i) administered purified ovine PRL (oPRL; 2400 μg/s.c. injection) or (ii) its diluent, polyvinylpyrrolidone (PVP), every 12 h, or (iii) received physiological testosterone replacement for 2 days. At 0, 2 and 6 days postcastration, norepinephrine (NE), epinephrine (E) and dopamine (DA) turnover were estimated by the α-methyl-p-tyrosine method in three micro-dissected hypothalamic structures: the diagonal band of Broca at the level of the organum vasculosum of the lamina terminalis (DBB(ovlt)), the medial preoptic nucleus (MPN) and the median eminence (ME). In control (PVP-treated) rats, serum LH concentrations increased eightfold at 2 and 6 days postcastration and this rise was prevented by testosterone. oPRL treatment transiently suppressed LH secretion at 2 but not 6 days postcastration. Castration significantly decreased basal rat PRL (rPRL) levels at 2 and 6 days and testosterone administration partially prevented this effect. NE turnover in the ME and E turnover in the MPN increased markedly at 2 and 6 days postcastration, and testosterone replacement for 2 days prevented these increases. Thus, noradrenergic neurones innervating the ME and adrenergic neurones innvervating the MPN may drive postcastration LH secretion by providing stimulatory afferent input to the GnRH neurones. It was striking to observe that oPRL blocked the increases in both ME NE and MPN E turnover at 2 but not 6 days postcastration. Hence, oPRL may transiently suppress LH release by an inhibitory action on these NE and E neurones. DA turnover in the DBB(ovlt) was significantly decreased by 6 days postcastration. Testosterone-treated (2 days postcastration) and oPRL-treated (2 and 6 days postcastration) rats exhibited turnover values indistinguishable from day 0 controls. Hence, the A14 dopaminergic neurones, which synapse on GnRH neurones in the rostral preoptic area and may exert an inhibitory effect on them, are positively regulated by PRL and perhaps by testosterone as well. Autoregulatory feedback suppression of endogenous rPRL secretion by oPRL was observed both 2 and 6 days postcastration. In contrast to the A14 dopaminergic neurones, turnover in the A12 tuberoinfundibular dopaminergic (TIDA) neurones innervating the ME increased significantly by 6 days postcastration in control rats while oPRL administration further increased ME DA turnover at both 2 and 6 days. Hence, autofeedback regulation of rPRL secretion persists through at least 6 days of oPRL exposure temporally associated with markedly increased turnover in the TIDA neurones. In summary, our results support the hypothesis that the inhibitory effect of PRL on postcastration LH release is mediated by suppression of the activity of NE neurones innervating the ME and E neurones terminating in the MPN which, with time, become refractory to continued PRL exposure. Journal of Endocrinology (1996) 148, 291–301


Endocrinology ◽  
2009 ◽  
Vol 150 (5) ◽  
pp. 2283-2291 ◽  
Author(s):  
Edith Sánchez ◽  
Miguel Angel Vargas ◽  
Praful S. Singru ◽  
Isel Pascual ◽  
Fidelia Romero ◽  
...  

Pyroglutamyl peptidase II (PPII), a highly specific membrane-bound metallopeptidase that inactivates TRH in the extracellular space, is tightly regulated by thyroid hormone in cells of the anterior pituitary. Whether PPII has any role in the region where axons containing hypophysiotropic TRH terminate, the median eminence, is unknown. For this purpose, we analyzed the cellular localization and regulation of PPII mRNA in the mediobasal hypothalamus in adult, male rats. PPII mRNA was localized in cells lining the floor and infralateral walls of the third ventricle and coexpressed with vimentin, establishing these cells as tanycytes. PPII mRNA extended in a linear fashion from the tanycyte cell bodies in the base of the third ventricle to its cytoplasmic and end-feet processes in the external zone of the median eminence in close apposition to pro-TRH-containing axon terminals. Compared with vehicle-treated, euthyroid controls, animals made thyrotoxic by the ip administration of 10 μg l-T4 daily for 1–3 d, showed dramatically increased accumulation of silver grains in the mediobasal hypothalamus and an approximately 80% increase in enzymatic activity. PPII inhibition in mediobasal hypothalamic explants increased TRH secretion, whereas ip injection of a specific PPII inhibitor increased cold stress- and TRH-induced TSH levels in plasma. We propose that an increase in circulating thyroid hormone up-regulates PPII activity in tanycytes and enhances degradation of extracellular TRH in the median eminence through glial-axonal associations, contributing to the feedback regulation of thyroid hormone on anterior pituitary TSH secretion.


2019 ◽  
Vol 127 (10) ◽  
pp. 697-705 ◽  
Author(s):  
Jafar Alipoor Hefshejanni ◽  
Homayoun Khazali

Abstract Aims The aim of the present study is to examine the orexin A (OXA) signaling can leave any impact on the hypothalamic-pituitary-gonadal (HPG) axis and this impact can be relayed through the pathway of RF amide-related peptide-3 (RFRP-3, the mammalian ortholog of the avian gonadotropin-inhibitory hormone)/G-protein coupled receptor (GPR)-147 (RFRP-3 receptor) as a novel target for controlling of HPG axis in the male rats. Materials and Methods Male rats were categorized randomly into experimental groups including control vehicle, OXA, and its antagonists’ group and went through to surgical cannulation into the third ventricle. After the intracerebroventricular injection of each solution, blood samples were collected for measurements of the LH and testosterone using radioimmunoassay method. Hypothalamus of the animals were isolated for analysis of the relative expression of Rfrp-3/Gpr-147 along with Gnrh gene by Real time-PCR. Also, in the different cohort of animal sexual behavior test was done. Results It was shown that OXA significantly decreases the mean serum level of the LH and testosterone and, at the same time, its antagonists neutralize this impact. Moreover, we demonstrated that OXA has reduced the hypothalamic gene expression of Gnrh and increased the expression of Rfrp-3 and Gpr-147 genes. While OXA antagonists neutralize this impact. Conclusions The results of this study are related to the impact of orexin on the HPG axis. It is recommended that RFRP-3/GPR-147 system as the interneural pathway relay the data of orexin to the neurons of GnRH.


1987 ◽  
Vol 114 (3) ◽  
pp. 383-388 ◽  
Author(s):  
Pekka Rauhala ◽  
Raimo K. Tuominen ◽  
Pekka T. Männistö

Abstract. The effect of β-endorphin, met-enkephalin and leu-enkephalin on cold-stimulated TSH and prolactin secretion after infusion of the drugs into the 3rd ventricle or into the posterior hypothalamus (PH) was investigated in male rats. β-endorphin (0.25 μg/rat, but not 0.05, 0.5 and 1 μg/rat) increased and met-enkephalin (20 and 100 μg/rat) decreased TSH secretion when infused into the 3rd ventricle. After bilateral infusion into the PH, β-endorphin (0.25 μg/side, but not 0.05 and 1 μg/side) increased TSH secretion, but met-enkephalin (1 and 10 μg/side) induced no changes. β-endorphin (0.05–1 μg/rat) and met-enkephalin (100 μg/rat) both increased prolactin secretion when infused into the 3rd ventricle, but only a high dose of β-endorphin (1 μg/side) was effective after infusion into the PH. Leu-enkephalin had no effect on TSH or prolactin secretion at the hypothalamic level. These results favour the hypothesis that μ-receptors mediate the inhibitory effect and other types (possible ε-receptors) of opiate receptors mediate the stimulatory effect of opioid peptides on TSH secretion at periventricular sites. However, only stimulatory μ-receptors affect prolactin secretion at these sites. After infusion into the PH, the effect of a high dose of β-endorphin on prolactin secretion may also be mediated through periventricular sites, but its effect on TSH secretion is evidently mediated through opiate receptors in the PH.


1977 ◽  
Vol 72 (3) ◽  
pp. 329-335 ◽  
Author(s):  
TAPIO RANTA ◽  
PEKKA MÄNNISTÖ ◽  
JOUKO TUOMISTO

SUMMARY The effects of two dopamine agonists (apomorphine and bromocriptine) and a dopamine antagonist (pimozide) on cold- or thyrotrophin releasing hormone (TRH)-induced TSH secretion were studied in normal male rats. Apomorphine given in various doses (0·5–10 mg/kg body wt) 10 min before exposure to cold significantly depressed TSH secretion. Large doses of bromocriptine (5–10 mg/kg body wt) given 1 h before exposure to cold, also blocked this response whereas a smaller dose (2·5 mg/kg body wt) given 30 min, 1, 3 or 6 h before cold exposure or repeated doses (0·1–2·5 mg/kg body wt) for 3 days did not modify cold-induced TSH secretion. Pimozide given in various doses (0·25–2·5 mg/kg body wt) 1 h before exposure to cold did not alter the cold response, but 2·5 mg/kg reversed the inhibition caused by apomorphine or bromocriptine. None of these drugs affected TRH-induced TSH secretion. These results suggest that there are no dopaminergic receptors on the pituitary thyrotrophs, but that dopamine might be an inhibitory transmitter in the brain involved in the regulation of TSH secretion in the rat.


1981 ◽  
Vol 91 (3) ◽  
pp. 415-425 ◽  
Author(s):  
F. A. ANTONI ◽  
G. B. MAKARA ◽  
GY. RAPPAY

The possible role of the neural connections of the medial-basal hypothalamus (MBH) in the maintenance of GH releasing activity of the pituitary stalk median eminence (SME) was investigated. Male rats, subjected to sham-operation and to complete and anterolateral cuts around the MBH were used 7–8 days after surgery. Electrical stimulation of neural structures within the MBH caused an increase of plasma GH in pentobarbitone- as well as in urethane-anaesthetized animals. In sham-operated rats the rise of plasma GH levels was apparent only after completion of 10 min of electrical stimulation, while in animals with complete or anterolateral cuts an increase was already evident during electrical stimulation. The results suggest that depolarization of somatostatin secreting fibres in the median eminence may be responsible for the delay in the rise of GH levels in sham-operated rats, while the increment can be attributed to a GH releasing principle in the hypothalamus. Acidic extracts of the SME of rats with complete or anterolateral cuts stimulated the release of GH by primary cultures of rat anterior pituitary cells. Microinjection of 0·05 SME equivalents of SME extract into the anterior pituitary gland of urethane-anaesthetized rats produced a rise in plasma GH levels within 3 min of injection. These data favour the existence of a GH releasing factor, and suggest that the ventromedial and arcuate hypothalamic nuclei are major sites of production of this releasing hormone.


2016 ◽  
Vol 310 (6) ◽  
pp. R476-R480 ◽  
Author(s):  
Lauren M. Stein ◽  
Gina L. C. Yosten ◽  
Willis K. Samson

Adropin, a recently described peptide hormone produced in the brain and liver, has been reported to have physiologically relevant actions on glucose homeostasis and lipogenesis, and to exert significant effect on endothelial function. We describe a central nervous system action of adropin to inhibit water drinking and identify a potential adropin receptor, the orphan G protein-coupled receptor, GPR19. Reduction in GPR19 mRNA levels in medial basal hypothalamus of male rats resulted in the loss of the inhibitory effect of adropin on water deprivation-induced thirst. The identification of a novel brain action of adropin and a candidate receptor for the peptide should extend and accelerate the study of the potential therapeutic value of adropin or its mimetics for the treatment of metabolic disorders.


1988 ◽  
Vol 254 (5) ◽  
pp. E595-E600 ◽  
Author(s):  
D. E. Suter ◽  
N. B. Schwartz ◽  
S. J. Ringstrom

To verify the inhibitory effect of cortisol (F) on secretion of luteinizing hormone (LH) 24 h postorchidectomy, we implanted cholesterol (C) or F subcutaneously into male rats, and 4 days later orchidectomized or sham orchidectomized them under ether anesthesia. We injected gonadotropin-releasing hormone (GnRH) or saline into these rats 24 h postorchidectomy, collected blood 30 min later, and measured LH and follicle-stimulating hormone (FSH) in serum and pituitaries. F inhibited GnRH-induced secretion of LH without affecting secretion of FSH. We then implanted C, corticosterone (B), or F into rats, performed the same surgeries, and collected pituitaries 24 h after surgery for quantitation of receptors for GnRH. Neither F nor B affected the number of receptors for GnRH or their affinity for a GnRH analogue. Suppression of LH in serum occurred without decreased pituitary content of LH. In contrast, F increased pituitary content of FSH. Implantation of progesterone in a similar experiment did not affect circulating concentrations or pituitary contents of FSH or LH. These data suggest that glucocorticoids may inhibit responsiveness to GnRH by some mechanism distal to the receptor for GnRH that affects only LH.


1979 ◽  
Vol 83 (2) ◽  
pp. 165-173 ◽  
Author(s):  
G. B. MAKARA ◽  
E. STARK ◽  
G. RAPPAY ◽  
M. KÁRTESZI ◽  
M. PALKOVITS

The activity of corticotrophin releasing factor (CRF) in extracts of the stalk median eminence (SME) complex proper (average protein content, 30·6 μg) of male rats was assayed by monolayer cultures of anterior pituitary cells using the release of immunoreactive ACTH. Extracts which were equivalent to 0·025 SME of control rats usually had detectable CRF activity, while there was no detectable activity in extracts of 0·4 SME equiv. taken 8 days after complete surgical isolation of the medial basal hypothalamus (MBH). The activity of CRF in extracts from rats with an anterolateral cut around the MBH was at least ten times less than that in the control rats. One day after placing an anterolateral cut around the MBH the ACTH releasing activity of the SME was not significantly different from that of the control animals but activity decreased significantly 3 days after the operation and was at least ten times less than in the control animals on day 7 after the operation. It is suggested that most of the CRF activity of the SME is contained in nerve fibres entering the neurohaemal region from outside the MBH and that transection of these fibres produced the fall in CRF content of the SME in rats with partial or total surgical isolation of the MBH.


Sign in / Sign up

Export Citation Format

Share Document